tau protein
Coverage of tau protein in the Nexus archive.
- An experimental Alzheimer's drug is showing some promise
An experimental Alzheimer's drug, diranersen, developed by Biogen, shows potential to slow cognitive decline by reducing tau protein levels, a key contributor to the disease. Early study results suggest it may offer benefits comparable to existing amyloid-targeting therapies, though further large-scale trials are needed to confirm efficacy.
- Alzheimer's tau protein has a surprising secret role in memory
Researchers discovered that tau protein is crucial for forming lasting memories by organizing memory-storing brain cells. A mouse study showed abnormal tau disrupts both new memory formation and recall of existing memories, linking it to Alzheimer's disease.
- Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
Biogen is advancing its Alzheimer's drug to a late-stage trial despite disappointing data, with signals suggesting the treatment decreases levels of tau and slows cognitive decline. The treatment appears to be most effective at the lowest dose. This development is a significant step in the search for an effective Alzheimer's treatment.
- Fish oil supplements linked to slower brain repair in some patients, study finds
A study suggests fish oil supplements, particularly their EPA component, may slow brain repair in individuals with repeated mild head injuries by destabilizing blood vessels and blocking repair signals, while also increasing tau protein buildup linked to brain diseases. Researchers emphasize that effects are context-dependent and findings are based on mice studies.
- Your vitamin D levels in midlife could shape your brain decades later
A study found that higher vitamin D levels in midlife may be linked to lower levels of tau protein later on, a key marker associated with dementia.